Table 2 Risk of bias for included studies
From: Systematic review of the health and societal effects of medication organisation devices
Items from Cochrane risk of bias tool | ||||||||
|---|---|---|---|---|---|---|---|---|
Study | Study design | Randomisation procedure | Concealment of allocation | Blinding of assessors | Blinding of treatment providers | Attrition addressed | All outcomes reported | Other risks of bias |
Becker [20] | RCT | ? | ? | ? | x | ? | ? | x |
Carruthers [32] | Audit | NA | NA | NA | NA | NA | ? | ✓ |
Crome [27] | RCT | ? | ? | ? | ? | ✓ | ? | ✓ |
Feetam [21] | Prospective | NA | NA | NA | NA | NA | ? | ✓ |
Huang [23] | RCT | ✓ | ✓ | ? | ? | ? | ? | ✓ |
Levings [33] | Audit | NA | NA | NA | NA | NA | ? | x |
MacIntosh [28] | RCT | ✓ | ? | ? | ? | ✓ | ? | ✓ |
McElnay [19] | Cross-section | NA | NA | NA | NA | NA | x | x |
Petersen [24] | Prospective | ? | ? | ? | ? | ✓ | ? | ✓ |
Rehder [25] | RCT | ? | ? | ? | ? | ? | ? | ✓ |
Roberts [18] | Cross-section, audit | NA | NA | NA | NA | NA | ? | x |
Ryan-Woolley [29] | RCT | ? | ? | ? | ? | ✓ | ? | ✓ |
Simmons [26] | RCT | ✓ | ? | ? | x | ✓ | ? | ✓ |
Skaer [31] | RCT | ? | ? | ? | ? | ? | ? | ✓ |
Skaer [30] | RCT | ? | ? | ? | ? | ? | ? | ✓ |
Stewart [34] | Cross-section | NA | NA | NA | NA | NA | ? | ✓ |
Wong [22] | RCT | ? | ? | ? | ? | x | ? | x |